Back to news

PBS Biotech Industrializes Cell Therapy Development with Rockwell Automation

PR Newswire•29/09/2026•11:00 ET
0

Key Highlights

  • ➤Rockwell Automation (ROK) technology embedded in PBS Biotech’s MiniPRO bioreactor platform
  • ➤MiniPRO supports up to 24 independently controlled bioreactors for parallel process development
  • ➤FactoryTalk software and Process Library provide integrated real-time process control and visibility
  • ➤MiniPRO integrates with PlantPAx distributed control systems for cell-therapy facility automation
  • ➤PBS Biotech reports MiniPRO performance consistent with larger-scale Vertical-Wheel bioreactors

Expert Statements

Sharon Harvey, Director of product management and strategy, PBS Biotech

“Rockwell technologies let us provide industrial-grade control of critical process parameters, so users are generating high-quality process data in an environment that looks and feels like commercial manufacturing.”

Sharon Harvey, Director of product management and strategy, PBS Biotech

“That's really advantageous because developers are able to introduce this during the product development stage and then evolve towards clinical and commercial manufacturing with history and control.”

Tom Bollenbach, Chief technology officer, ARMI

“Typically, you don't see this control in a system as small as the MiniPRO.”

Tom Bollenbach, Chief technology officer, ARMI

“With our first integrated manufacturing line, our biggest challenge was getting the process control system to sequentially hand off between subsystems.”

Tom Bollenbach, Chief technology officer, ARMI

“Because the MiniPRO has Rockwell controls, system integration is streamlined.”

Tom Bollenbach, Chief technology officer, ARMI

“When we talk to the supervisory system that makes hand-offs happen, it's very easy to get them to talk to each other.”

Tom Bollenbach, Chief technology officer, ARMI

“That enables us to build bigger manufacturing lines.”

Matt Weaver, Vice president, global industry - life sciences, Rockwell Automation

“As cell therapy programs advance, seamless tech transfers between development outputs and manufacturing requirements help reduce risk during scale-up.”

Matt Weaver, Vice president, global industry - life sciences, Rockwell Automation

“By introducing a widely used automation platform during process development, the MiniPRO helps teams preserve process knowledge and control as they progress toward clinical and commercial manufacturing.”

PBS Biotech Industrializes Cell Therapy Development with Rockwell Automation PR Newswire

Leading bioreactor manufacturer accelerates time-to-results and simplifies global deployment with standardized automation

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in